Development of Clinical Pathway for Prevention and Control of Multidrug-Resistant Organisms Transmission in Hospital
Keywords:
Clinical Pathway, Prevention and Control, Multidrug-Resistant Organisms Transmission, HospitalAbstract
Transmission of multidrug-resistant organisms in hospitals has a direct impact on patients, health care personnel, the hospital, community, and the nation. This developmental research aimed to develop a clinical pathway for prevention and control of multidrug-resistant organism transmission in the medical department at a regional hospital during October 2015 to January 2016. Study samples included 131 health care personnel who worked in the medical department and related units. Ten patients infected or suspected of multidrug-resistant organism infection and admitted at the medical department were included in the test using the clinical pathway implementation process. The process for developing the clinical pathway was based on the framework of Cheah. Three development steps were included: 1) assessing and analyzing the situation, 2) designing the clinical pathway, and 3) testing the implementation of clinical pathway. The data collection instruments consisted of a demographic data record form and questionnaire assessing the opinions of health care personnel towards the use of the clinical pathway. The content validity of the questionnaire was examined by 5 experts and the content validity index was .90. Data were analyzed using descriptive statistics and data categorization.
The results revealed that the clinical pathway for prevention and control of multidrug-resistant organisms included: screening, using contact precautions, wearing masks, cleaning patients’ bodies with 2% Chlorhexidine gluconate, cleaning the environment, reminding the health care personnel, proper transfer of patient between units, active surveillance, and being careful of medical errors and adverse events. Most health care personnel agreed that this clinical pathway was clear, convenient, practical and appropriate for implementation in their units.
This research suggests that this clinical pathway for prevention and control of multidrug-resistant organisms should be routinely implemented in the hospital.
References
Apisarnthanarak, A., Pinitchai, U., Thongphubeth, K., Yuekyen, C., Warren, D. K., Fraser, V. J. (2008).A multifaceted intervention to reduce pandrug-resistant Acinetobacter baumannii colonization and infection in 3 intensive care units in a Thai tertiary care center: a 3-year study. Clinical Infectious Diseases, 47(6), 760-767.
Centers for Disease Control and Prevention [CDC]. (2013). Antibiotic resistance threats in the United States, 2013. Retrieved from http://www.cdc.gov/drugresistance/threat-report -2013/
Cheah, J. (2000). Development and implementation of a clinical pathway programme in an acute care general hospital in Singapore. International Journal for Quality in Health Care, 12( 5), 403-412.
Chen, W., Li, S., Li, L., Wu, X., & Zhang, W. (2013). Effects of daily bathing with chlorhexidine and acquired infection of methicillin-resistant Staphylococcus aure us and vancomycin-resistant Enterococcus: a meta-analysis. Journal of Thoracic Disease, 5(4), 518-524.
Ciobotaro, P., Oved, M., Nadir, E., Bardenstein, R., & Zimhony, O. (2011). An effective intervention to limit the spread of an epidemic carbapenem-resistant Klebsie lla pneumoniae strain in an acute care setting: from theory to practice. American Journal of Infection Control, 39 (8), 671-677.
European Centre for Disease Prevention and Control [ECDC]. ( 2012). EU action on antimicrobial resistance–european antibiotic awareness day. Retrieved from http://ecdc.europa.eu/en/aboutus/organisation/ Director%20Speeches/1201_Director_speech_EU_health_prize_journalists.pdf
Every, N., Hochman, J., Becker, R., Kopecky, S., & Cannon, C. P. (2000). Critical pathways:A review. Circulation, 101 (4), 461-465.
Fritz, S. A., Hogan, P. G., Singh, L. N., Thompson, R. M., Wallace, M. A., Whitney, K., ... Fraser, V. J.(2014). Contamination of environmental surfaces with Staphyloco ccus aureus in households with children infected with methicillin-resistant S. aureus. JAMA Pediatric,168(11), 1030-1038.
Herbert, S., Halvorsen, D. S., Leong, T., Franklin, C., Harrington, G., & Spelman, D. (2007). Large outbreak of infection and colonization with gram-negative patho gens carrying the metallo-β-lactamase gene bla IMP-4 at a 320-bed tertiary hospital in Aus tralia. Infection Control & Hospital Epidemiology, 28 (1), 98-101.
Ho, C., Lau, A., Cimon, K., Farrah, K., & Gardam, M. (2013). Sc reening, isolation, and decolonization strategies for Vancomycin-Resistant Enterococci or Extended Spe ctrum Beta-Lactamase-producing organisms: A systematic review of the clinical evidence and health services impact. Canadian Agency for Drugs and Technologies in Health, 3 (1), e3102.
Huskins, W. C., Huckabee, C. M., O’Grady, N. P., Murray, P., Kopetskie, H., Zimmer, L., ... Samore,M. (2011). Intervention to reduce transmission of resistant bacteria in intensive care.New England Journal of Medicine, 364 (15), 1407-1418.
Juylek, N., Picheansathian, W., & Klunklin, P. (2016). Developm ent of Risk Factor Scoring System of Multidrug-resistant Microorganism Infection Among In-Patents. Nursing Journal, 43 (3), 69-80. (In Thai)
Kac, G., Grohs, P., Durieux, P., Trinquart, L., Gueneret, M., Rodi, A., ... Meyer, G. (2007). Impact of electronic alerts on isolation precautions for patients with mu ltidrug-resistant bacteria.Archives of Internal Medicine, 167(19), 2086-2090.
Karki, S., & Cheng, A. C. (2012). Impact of non-rinse skin cleansing with chlorhexidine gluconate on prevention of healthcare-associated infections and colonization with multi-resistant organisms: a systematic review. Journal of Hospital Infection, 82 (2), 71-84.
Kim, N. H., Han, W. D., Song, K. H., Seo, H. K., Shin, M. J., Kim, T. S., ... Kim, H. B. (2014).Successful containment of carbapenem-resistant Enterobacteri aceae by strict contact precautions without active surveillance. American Journal of Infection Control, 42 (12),1270-1273.
Knoester, M., de Boer, M. G. J., Maarleveld, J. J., Claas, E. C. J., Bernards, A. T., de Jonge, E., ... Veldkamp, K. E. (2014). An integrated approach to control a prolonged outbreak of multidrug resistant Pseudomonas aeruginosa in an intensive care unit. Clinical Microbiology and Infection, 20 (4), O207-O215.
Kramer, A., Schwebke, I., & Kampf, G. (2006). How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infectious Diseases, 6 (1), 130-137.
Lacey, S., Flaxman, D., Scales, J., & Wilson. A. (2001). The usefulness of masks in preventing transient carriage of epidemic methicillin-resistant Staphyloco ccus aureus by healthcare workers. Journal of Hospital Infection, 48 (4), 308-311.
Maslikowska, J. A., Walker, S. A. N., Elligsen, M., Mittmann, N., Palmay, L., Daneman, N., & Simor,A. (2016). Impact of infection with extended-spectrum b-lactamase-producing Escherichia coli or Klebsiella species on outcome and hospitalization costs. Journal of Hospital Infection, 92 (1), 33-41.
National Antimicrobial Resistance Surveillance Center, Thailand. (2014). Antibiograms. Retrieved from http://narst.dmsc. moph. go.th/antibiograms.html (In Thai)
Özgür, E. S., Horasan, E. S., Karaca, K., Ersöz, G., Atış, S. N., & Kaya, A. (2014). Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumann ii: risk factors, clinical features, and outcomes. American Journal of Infection Control, 42 (2), 206-208.
Rotter, T., Kinsman, L., James, E., Machotta, A., Gothe, H., Willis, J., ... Kugler, J. (2010). Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs. Retrieved from http://2.cochrane.org/reviews/en/ab006632.Html
Shah, N., Castro-Sánchez, E., Charani, E., Drumright, L. N., & Holmes, A. H. (2015). Towards changing healthcare workers’ behaviour: a qualitative study exploring non-compliance through appraisals of infection prevention and control practi ces. Journal of Hospital Infection, 90 (2), 126-134.
Siegel, J. D., Rhinehart, E., Jackson, M., Chiarello, L., & Committee, H. I. C. P. A. (2007). Management of multidrug-resistant organisms in health care settings, 2006. American Journal of Infection Control, 35(10), S165-S193.
Strategy and Planning Division Ministry of Public Health, Thail and. (2013). Manaul Health Office(1sted.). Bangkok: The War Veterans Organization officer of Printing Mill. (In Thai)
The Joanna Briggs Institute Levels of Evidence and Grade of Recommendation Working Party.(2014).Supporting document for the Joanna Briggs Institute levels of evidence and grades of recommendation. Retrieved from http://joannabriggs.org/jbi-approach.html#tabbed-nav=Levels-of-Evidence.
Wijitjammaree, N. (2011).Organization Communication (2nd ed.). Bangkok: Kasetsart University Press. (In Thai)
Wolstenholme, S. (2005). Pathway to success- the introduction of an integrated care pathway for delivery of care to methicillin-resistant Staphylococcus aureus - positive patients. Journal of Infection Prevention, 6 (6), 20-24.
World Health Organization. (2014). Antimicrobial resistance global report on surveillance. Retrieved from http://www.who.int/drugresistance/documents/surveillancer eport/en/
Zahar, J. R., Garrouste-Orgeas, M., Vesin, A., Schwebel, C., Bonadona, A., Philippart, F., ... Timsit, J.F. (2013). Impact of contact isolation for multidrug-resistant organisms on the occurrenceb of medical errors and adverse events. Intensive Care Medicine, 39 (12), 2153-2160
Downloads
Published
How to Cite
Issue
Section
License
บทความที่ได้รับการตีพิมพ์เป็นลิขสิทธิ์ของวารสารพยาบาลสาร
ข้อความที่ปรากฏในบทความแต่ละเรื่องในวารสารวิชาการเล่มนี้เป็นความคิดเห็นส่วนตัวของผู้เขียนแต่ละท่านไม่เกี่ยวข้องกับมหาวิทยาลัยเชียงใหม่ และคณาจารย์ท่านอื่นๆในมหาวิทยาลัยฯ แต่อย่างใด ความรับผิดชอบองค์ประกอบทั้งหมดของบทความแต่ละเรื่องเป็นของผู้เขียนแต่ละท่าน หากมีความผิดพลาดใด ๆ ผู้เขียนแต่ละท่านจะรับผิดชอบบทความของตนเองแต่ผู้เดียว
